S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Hookipa Pharma (HOOK) Short Interest Ratio & Short Volume

$0.73
-0.03 (-3.93%)
(As of 04/19/2024 ET)

Hookipa Pharma Short Interest Data

Current Short Volume
315,900 shares
Previous Short Volume
333,400 shares
Change Vs. Previous Month
-5.25%
Dollar Volume Sold Short
$224,920.80
Short Interest Ratio / Days to Cover
0.6
Last Record Date
March 31, 2024
Outstanding Shares
98,950,000 shares
Float Size
70,400,000 shares
Short Percent of Float
0.45%
Today's Trading Volume
443,545 shares
Average Trading Volume
525,679 shares
Today's Volume Vs. Average
84%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Hookipa Pharma ?

Sign up to receive the latest short interest report for Hookipa Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HOOK Short Interest Over Time

HOOK Days to Cover Over Time

HOOK Percentage of Float Shorted Over Time

Hookipa Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024315,900 shares $224,920.80 -5.3%0.5%0.6 $0.71
3/15/2024333,400 shares $239,714.60 +11.3%0.6%0.1 $0.72
2/29/2024299,500 shares $230,016.00 -10.0%0.5%0.1 $0.77
2/15/2024332,600 shares $219,516.00 -25.4%0.6%0.1 $0.66
1/31/2024446,100 shares $277,072.71 -28.1%0.8%0.2 $0.62
1/15/2024620,200 shares $474,390.98 -21.0%1.0%0.3 $0.76
12/31/2023785,400 shares $636,174.00 +142.9%1.3%0.3 $0.81
12/15/2023323,300 shares $211,114.90 -29.6%0.4%0.1 $0.65
11/30/2023459,000 shares $261,171.00 +99.5%0.6%1 $0.57
11/15/2023230,100 shares $109,297.50 -26.7%0.3%0.5 $0.48
10/31/2023313,900 shares $135,604.80 -10.5%0.4%0.9 $0.43
10/15/2023350,800 shares $191,536.80 -12.1%0.5%0.9 $0.55
9/30/2023399,000 shares $245,784.00 +68.9%0.5%1 $0.62
9/15/2023236,200 shares $165,340.00 +5.2%0.3%0.5 $0.70
8/31/2023224,600 shares $147,113.00 -20.5%0.3%0.3 $0.66
8/15/2023282,400 shares $206,152.00 -2.0%0.4%0.3 $0.73
7/31/2023288,200 shares $227,678.00 -64.2%0.4%0.2 $0.79
7/15/2023805,900 shares $710,964.98 -11.5%1.2%0.5 $0.88
6/30/2023910,600 shares $801,328.00 +26.3%1.4%0.6 $0.88
6/15/2023721,000 shares $771,470.00 +951.0%1.1%0.5 $1.07
5/31/202368,600 shares $89,866.00 -78.2%0.1%0.1 $1.31
5/15/2023314,900 shares $585,714.00 No Change0.7%0.4 $1.86
10/31/2022879,900 shares $1.14 million -4.3%N/A0.9 $1.29
10/15/2022919,600 shares $1.09 million -9.8%N/A1 $1.19
9/30/20221,020,000 shares $1.37 million +2.0%N/A4.9 $1.34
9/15/20221,000,000 shares $1.41 million -3.9%N/A3.7 $1.41
8/31/20221,040,000 shares $1.55 million -17.5%N/A3.2 $1.49
8/15/20221,260,000 shares $2.17 million -46.2%N/A3.1 $1.73
7/31/20222,340,000 shares $3.21 million -2.5%N/A5.3 $1.37
7/15/20222,400,000 shares $3.96 million -29.6%N/A5.4 $1.65
6/30/20223,410,000 shares $5.56 million -14.1%N/A5.6 $1.63
6/15/20223,970,000 shares $6.67 million -3.6%N/A4.6 $1.68
5/31/20224,120,000 shares $7.09 million -0.7%N/A4.2 $1.72
5/15/20224,150,000 shares $5.69 million +2.7%N/A1.2 $1.37
4/30/20224,040,000 shares $6.06 million +5.2%N/A0.6 $1.50
4/15/20223,840,000 shares $6.87 million -2.5%N/A0.6 $1.79
3/31/20223,940,000 shares $8.98 million +1.8%N/A0.6 $2.28
3/15/20223,870,000 shares $5.84 million -16.8%N/A0.6 $1.51
2/28/20224,650,000 shares $11.16 million +63.7%27.7%0.8 $2.40
2/15/20222,840,000 shares $3.81 million +15.5%15.4%0.5 $1.34
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

HOOK Short Interest - Frequently Asked Questions

What is Hookipa Pharma's current short interest?

Short interest is the volume of Hookipa Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 315,900 shares of HOOK short. 0.45% of Hookipa Pharma's shares are currently sold short. Learn More on Hookipa Pharma's current short interest.

What is a good short interest ratio for Hookipa Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOOK shares currently have a short interest ratio of 1.0. Learn More on Hookipa Pharma's short interest ratio.

Which institutional investors are shorting Hookipa Pharma?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Hookipa Pharma: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Hookipa Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Hookipa Pharma's floating shares are currently sold short.

Is Hookipa Pharma's short interest increasing or decreasing?

Hookipa Pharma saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 315,900 shares, a decline of 5.2% from the previous total of 333,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Hookipa Pharma's float size?

Hookipa Pharma currently has issued a total of 98,950,000 shares. Some of Hookipa Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hookipa Pharma currently has a public float of 70,400,000 shares.

How does Hookipa Pharma's short interest compare to its competitors?

0.45% of Hookipa Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Hookipa Pharma: YS Biopharma Co., Ltd. (0.54%), Spero Therapeutics, Inc. (1.21%), Affimed (1.51%), Oncolytics Biotech Inc. (1.23%), Eton Pharmaceuticals, Inc. (0.98%), BioXcel Therapeutics, Inc. (10.54%), Chimerix, Inc. (1.56%), PMV Pharmaceuticals, Inc. (6.40%), InflaRx (0.66%), SELLAS Life Sciences Group, Inc. (9.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Hookipa Pharma stock?

Short selling HOOK is an investing strategy that aims to generate trading profit from Hookipa Pharma as its price is falling. HOOK shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hookipa Pharma?

A short squeeze for Hookipa Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HOOK, which in turn drives the price of the stock up even further.

How often is Hookipa Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOOK, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:HOOK) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners